1. Home
  2. CTOR
  3. CTOR News

Latest CITIUS ONCOLOGY INC (CTOR) News on July 13, 2025

US High Growth Tech Stocks with Promising Potential
CTOR

Simply Wall St.

13 days ago

US High Growth Tech Stocks with Promising Potential

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025
CTOR

PR Newswire

a month ago

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025

Citius Oncology Enters into Distribution Services Agreement with Cardinal Health
CTOR

PR Newswire

a month ago

Citius Oncology Enters into Distribution Services Agreement with Cardinal Health

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update
CTOR

PR Newswire

2 months ago

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update

Citius Oncology, Inc. (NASDAQ:CTOR) Is Expected To Breakeven In The Near Future
CTOR

Simply Wall St.

2 months ago

Citius Oncology, Inc. (NASDAQ:CTOR) Is Expected To Breakeven In The Near Future

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services
CTOR

PR Newswire

5 months ago

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025
CTOR

PR Newswire

6 months ago

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

Citius Oncology to explore strategic alternatives
CTOR

TipRanks

6 months ago

Citius Oncology to explore strategic alternatives

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives
CTOR

PR Newswire

6 months ago

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital
CTOR

TipRanks

6 months ago

Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
CTOR

PR Newswire

7 months ago

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
CTOR

PR Newswire

7 months ago

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Citius Oncology, Inc.'s (NASDAQ:CTOR) Path To Profitability
CTOR

Simply Wall St.

7 months ago

Citius Oncology, Inc.'s (NASDAQ:CTOR) Path To Profitability

Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
CTOR

PR Newswire

10 months ago

Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Share on Social Networks: